Search Results - "Pelster, Meredith" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C

by Yaeger, Rona, Weiss, Jared, Pelster, Meredith S., Spira, Alexander I., Barve, Minal, Ou, Sai-Hong I., Leal, Ticiana A., Bekaii-Saab, Tanios S., Paweletz, Cloud P., Heavey, Grace A., Christensen, James G., Velastegui, Karen, Kheoh, Thian, Der-Torossian, Hirak, Klempner, Samuel J.
Published in The New England journal of medicine (05.01.2023)

Get full text

Journal Article

Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study

Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study

by Pelster, Meredith S, Gruschkus, Stephen K, Bassett, Roland, Gombos, Dan S, Shephard, Michael, Posada, Liberty, Glover, Maura S, Simien, Rinata, Diab, Adi, Hwu, Patrick, Carter, Brett W, Patel, Sapna P
Published in Journal of clinical oncology (20.02.2021)

Get full text

Journal Article

Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trials

Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trials

by Pelster, Meredith S., Amaria, Rodabe N.
Published in Therapeutic Advances in Medical Oncology (01.02.2019)

Get full text

Book Review Journal Article

Pembrolizumab-induced mucositis in a patient with recurrent hypopharynx squamous cell cancer

Pembrolizumab-induced mucositis in a patient with recurrent hypopharynx squamous cell cancer

by Pelster, Meredith S, Mott, Frank, Lewin, Jan
Published in The Laryngoscope (01.04.2020)

Get more information

Journal Article

Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation

Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation

by Bekaii-Saab, Tanios S, Yaeger, Rona, Spira, Alexander I, Pelster, Meredith S, Sabari, Joshua K, Hafez, Navid, Barve, Minal, Velastegui, Karen, Yan, Xiaohong, Shetty, Aditya, Der-Torossian, Hirak, Pant, Shubham
Published in Journal of clinical oncology (01.09.2023)

Get full text

Journal Article

Neoadjuvant Immunotherapy for Locally Advanced Melanoma

Neoadjuvant Immunotherapy for Locally Advanced Melanoma

by Pelster, Meredith S., Amaria, Rodabe N.
Published in Current treatment options in oncology (05.02.2020)

Get full text

Journal Article

Adagrasib in Advanced Solid Tumors Harboring a KRAS G12C Mutation

Adagrasib in Advanced Solid Tumors Harboring a KRAS G12C Mutation

by Bekaii-Saab, Tanios S, Yaeger, Rona, Spira, Alexander I, Pelster, Meredith S, Sabari, Joshua K, Hafez, Navid, Barve, Minal, Velastegui, Karen, Yan, Xiaohong, Shetty, Aditya, Der-Torossian, Hirak, Pant, Shubham
Published in Journal of clinical oncology (01.09.2023)

Get full text

Journal Article

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer

by Yaeger, Rona, Uboha, Nataliya V, Pelster, Meredith S, Bekaii-Saab, Tanios S, Barve, Minal, Saltzman, Joel, Sabari, Joshua K, Peguero, Julio A, Paulson, Andrew Scott, Jänne, Pasi A, Cruz-Correa, Marcia, Anderes, Kenna, Velastegui, Karen, Yan, Xiaohong, Der-Torossian, Hirak, Klempner, Samuel J, Kopetz, Scott E
Published in Cancer discovery (03.06.2024)

Get full text

Journal Article

Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma

Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma

by Pelster, Meredith S., Silverman, Ian M., Schonhoft, Joseph D., Johnson, Adrienne, Selenica, Pier, Ulanet, Danielle, Rimkunas, Victoria, Reis-Filho, Jorge S.
Published in NPJ precision oncology (01.04.2024)

Get full text

Journal Article

652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors

652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors

by Naing, Aung, Mamdani, Hirva, Barve, Minal, Pelster, Meredith, Haymaker, Cara, Derbala, Mohamed, Goon, Jack, Darko, Samuel, Murphy, Julie, Gorelik, Lauren, Bierly, Allison, Ferrando-Martinez, Sara, Lee, Byung Ha, Yang, Se Hwan, Lee, Siyoung, Chaney, Marya, Kim, Richard D
Published in Journal for immunotherapy of cancer (01.11.2023)

Get full text

Journal Article

692 COMMANDER-001: safety data from a phase I/II dose escalation/expansion study of SQZ-eAPC-HPV, a cell-based mRNA therapeutic cancer vaccine for HPV16+ solid tumors

692 COMMANDER-001: safety data from a phase I/II dose escalation/expansion study of SQZ-eAPC-HPV, a cell-based mRNA therapeutic cancer vaccine for HPV16+ solid tumors

by Pelster, Meredith, Jimeno, Antonio, Wise-Draper, Trisha, Park, Jong Chul, Villaflor, Victoria, Rodabaugh, Kerry J, Iams, Wade T, Jennings, Julia, Morrison, Melinda, Miselis, Nathan, Loughhead, Scott, Bernstein, Howard, Warren, Marshelle S, Moser, Justin C, Gordon, Michael S
Published in Journal for immunotherapy of cancer (01.11.2023)

Get full text

Journal Article

611 XTX202–01/02–001, Phase 1/2 first-in human study of XTX202, a masked, tumor-activated IL-2βγ, in patients with advanced solid tumors: results from phase 1

611 XTX202–01/02–001, Phase 1/2 first-in human study of XTX202, a masked, tumor-activated IL-2βγ, in patients with advanced solid tumors: results from phase 1

by Hanna, Diana, Zakharia, Yousef, Goel, Sanjay, Hurley, Randy, Pelster, Meredith, El-Khoueiry, Anthony, Thomas, Jacob, Powderly, John, Miller, David, Wu, Richard, Chmielowski, Bartosz, Rapisuwon, Suthee, Gupta, Anurag, Duncan, Meghan, Siu, Aika, Patel, Ekta, Fantini, Damiano, Crowe, David, Paramasivan, Sattanathan, Lee, George, Luptakova, Katarina, McKean, Meredith
Published in Journal for immunotherapy of cancer (01.11.2023)

Get full text

Journal Article

Phase 1 study of ASP1002, a bispecific antibody targeting claudin 4 (CLDN4) and CD137, in patients with locally advanced (LA) or metastatic solid tumors that express CLDN4

Phase 1 study of ASP1002, a bispecific antibody targeting claudin 4 (CLDN4) and CD137, in patients with locally advanced (LA) or metastatic solid tumors that express CLDN4

by Pelster, Meredith, Marron, Thomas Urban, Friend, Brian D, Fan, Alan, Yang, Jianning, Spira, Alexander I.
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

A phase I study of EO-3021 in adult patients with solid tumors likely to express CLDN18.2

A phase I study of EO-3021 in adult patients with solid tumors likely to express CLDN18.2

by Pelster, Meredith, Perez, Cesar Augusto, Chandana, Sreenivasa R, Uboha, Nataliya Volodymyrivna, Swami, Ashwin, McDonald, Holly, Srivastava, Jaya, Barve, Minal A.
Published in Journal of clinical oncology (20.01.2024)

Get full text

Journal Article

ONCX-NAV-G201: A phase 2 basket study of navicixizumab monotherapy or in combination with chemotherapy in patients with select advanced solid tumors—Colorectal Cancer Cohort (trial in progress)

ONCX-NAV-G201: A phase 2 basket study of navicixizumab monotherapy or in combination with chemotherapy in patients with select advanced solid tumors—Colorectal Cancer Cohort (trial in progress)

by Oberstein, Paul Eliezer, Pelster, Meredith, Culm, Kerry, Chamberlain Santos, Valerie, Koustenis, Andrew, Mockbee, Colleen M., Youssoufian, Hagop, Krauss, John C.
Published in Journal of clinical oncology (01.02.2023)

Get full text

Journal Article

A multicenter, open-label, phase 1a/b study of HC-7366, a modulator of integrated stress response (ISR) kinase GCN2 in subjects with advanced solid tumors

A multicenter, open-label, phase 1a/b study of HC-7366, a modulator of integrated stress response (ISR) kinase GCN2 in subjects with advanced solid tumors

by Pelster, Meredith, Torre, Marcio, Kannan, Geoffrey Sumithran, Gargano, Michele Anne, Mattson, Paulette, Rathmann, Blaine, Bose, Nandita, Iglesias, Jose Luis
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

Preliminary results of a phase 1/2, first-in-human, open-label, dose escalation study of ZL-1211 (anti-Claudin 18.2 mAb) in patients with unresectable or metastatic solid tumors

Preliminary results of a phase 1/2, first-in-human, open-label, dose escalation study of ZL-1211 (anti-Claudin 18.2 mAb) in patients with unresectable or metastatic solid tumors

by Sharma, Sunil, Starodub, Alexander, Xu, Nong, Chaudhry, Arvind, Sun, Meili, Pelster, Meredith, Fu, Yinjia, Zhang, Xinyu, Huang, Zhao, Liu, Wenyu, Hsu, Karl
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Tumor infiltrating lymphocyte (TIL) harvest and ex vivo expansion from primary and metastatic (met) uveal melanoma (UM) tumors

Tumor infiltrating lymphocyte (TIL) harvest and ex vivo expansion from primary and metastatic (met) uveal melanoma (UM) tumors

by Patel, Sapna Pradyuman, Forget, Marie-Andree, Kreidieh, Firas Y., Pelster, Meredith, Davies, Michael A., Amaria, Rodabe Navroze, Gombos, Dan S., Bernatchez, Chantale
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

A phase 1/2, first-in-human trial of ZB131, a novel antibody targeting cancer-specific plectin (CSP) in advanced solid tumors

A phase 1/2, first-in-human trial of ZB131, a novel antibody targeting cancer-specific plectin (CSP) in advanced solid tumors

by Sommerhalder, David, Piha-Paul, Sarina A., Pelster, Meredith, Borad, Mitesh J., Vandross, Andrae Lavon, Spira, Alexander I., Perez, Samantha, Brinton, Lindsey, Kelly, Kimberly, Ramanathan, Ramesh K., Reilley, Matthew
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRAS G12C mutation

KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRAS G12C mutation

by Pant, Shubham, Yaeger, Rona, Spira, Alexander I., Pelster, Meredith, Sabari, Joshua K., Hafez, Navid, Barve, Minal A., Velastegui, Karen, Yan, Xiaohong, Der-Torossian, Hirak, Bekaii-Saab, Tanios S.
Published in Journal of clinical oncology (20.04.2023)

Get full text

Journal Article